help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0503
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/6/1618    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kinugawa, K.
Right arrow Articles by Long, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinugawa, K.
Right arrow Articles by Long, C. S.
Molecular Endocrinology 19 (6): 1618-1628
Copyright © 2005 by The Endocrine Society

Thyroid Hormone Induces Cardiac Myocyte Hypertrophy in a Thyroid Hormone Receptor {alpha}1-Specific Manner that Requires TAK1 and p38 Mitogen-Activated Protein Kinase

Koichiro Kinugawa, Mark Y. Jeong, Michael R. Bristow and Carlin S. Long

Division of Cardiology (M.R.B., C.S.L.), University of Colorado Health Sciences Center, Cardiology Section (C.S.L.), Denver Health Medical Center, Denver, Colorado 80204

Address all correspondence and requests for reprints to: Carlin S. Long, M.D., 777 Bannock Street, Box 0960, Denver, Colorado 80204. E-mail: clong{at}dhha.org.

Alterations in TR [thyroid hormone (TH) receptor]1 isoform expression have been reported in models of both physiologic and pathologic cardiac hypertrophy as well as in patients with heart failure. In this report, we demonstrate that TH induces hypertrophy as a direct result of binding to the TR{alpha}1 isoform and, moreover, that overexpression of TR{alpha}1 alone is also associated with a hypertrophic phenotype, even in the absence of ligand. The mechanism of TH and TR{alpha}1-specific hypertrophy is novel for a nuclear hormone receptor and involves the transforming growth factor ß-activated kinase (TAK1) and p38. Mitigating TR{alpha}1 effects, both TR{alpha}2 and TRß1 attenuate TR{alpha}1-induced myocardial growth and gene expression by diminishing TAK1 and p38 activities, respectively. These findings refine our previous observations on TR expression in the hypertrophied and failing heart and suggest that manipulation of thyroid hormone signaling in an isoform-specific manner may be a relevant therapeutic target for altering the pathologic myocardial program.

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  TRβ  |  RXRα  |  RXRβ  |  RXRγ
Ligands:   Thyroid hormone



This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
E. Ortega, J. Koska, N. Pannacciulli, J. C Bunt, and J. Krakoff
Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals
Eur. J. Endocrinol., February 1, 2008; 158(2): 217 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
I. Irrcher, D. R. Walkinshaw, T. E. Sheehan, and D. A. Hood
Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal muscle in vivo
J Appl Physiol, January 1, 2008; 104(1): 178 - 185.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. D. Belke, B. Gloss, E. A. Swanson, and W. H. Dillmann
Adeno-Associated Virus-Mediated Expression of Thyroid Hormone Receptor Isoforms-{alpha}1 and -{beta}1 Improves Contractile Function in Pressure Overload-Induced Cardiac Hypertrophy
Endocrinology, June 1, 2007; 148(6): 2870 - 2877.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C. Pantos, I. Mourouzis, C. Xinaris, A. D Kokkinos, K. Markakis, A. Dimopoulos, M. Panagiotou, T. Saranteas, G. Kostopanagiotou, and D. V Cokkinos
Time-dependent changes in the expression of thyroid hormone receptor {alpha}1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling
Eur. J. Endocrinol., April 1, 2007; 156(4): 415 - 424.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. Salem, P. B. Kenney, C. E. Rexroad 3rd, and J. Yao
Microarray gene expression analysis in atrophying rainbow trout muscle: a unique nonmammalian muscle degradation model
Physiol Genomics, December 13, 2006; 28(1): 33 - 45.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kenessey and K. Ojamaa
Thyroid Hormone Stimulates Protein Synthesis in the Cardiomyocyte by Activating the Akt-mTOR and p70S6K Pathways
J. Biol. Chem., July 28, 2006; 281(30): 20666 - 20672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Kenessey, E. A. Sullivan, and K. Ojamaa
Nuclear localization of protein kinase C-{alpha} induces thyroid hormone receptor-{alpha}1 expression in the cardiomyocyte
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H381 - H389.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society